Skip to content

Clinal Trial With Oral and Local drugs in management of Tinea Corporis

Efficacy and safety of Itrifal Shahtara and Marham Daad with Comparison of Majoon Ushba and Marham Raal in the management of Quba (Tinea Corporis) An Open-Labeled Randomized Comparative Clinical Study. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/066758
Enrollment
60
Registered
2024-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Oral- Itrifal Shahtara Local- Marham daad: 1.Itrifal Shahtara- 5-7gm Frequency-Once day. Route of administration- Orally Duration- 6 weeks 2.Marham Daad frequency- Twice a day Route of

Sponsors

Government Tibbi College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients those who have subjective and objective signs and symptoms or diagnosed case of Tinea corporis. 2.Patients with positive mycology test(KOH positive). 3.Patients of either gender. 4.Patients in the age group of 18-50 years. 5.Patients who have agreed to participate and sign the informed consent form and follow the protocol.

Exclusion criteria

Exclusion criteria: 1.Co-morbid conditions of the participant like DM, HTN, CAD, CKD and other autoimmune diseases. 2.Participants suffering from concomitant diseases like Psoriasis and eczema. 3.Pregnant or lactating women. 4.Known cases of immuno-compromised states like AIDS, Malignancies and on immuno-suppressive drugs 5.Participants fail to attend treatment schedule regularly.

Design outcomes

Primary

MeasureTime frame
Total Sign and symptom score(TSSS)Timepoint: 1st week to 6 weeks

Secondary

MeasureTime frame
Conversion to Negative mycology testTimepoint: At 6 Week

Countries

India

Contacts

Public ContactDr Md Tanwir alam

Government Tibbi College and Hospital

dr.razi.ahmed91@gmail.com7909035622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026